|
Malignant neoplasm of lung
|
0.070 |
PosttranslationalModification
|
disease |
BEFREE |
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
|
17890317 |
2007 |
|
Carcinoma of lung
|
0.070 |
PosttranslationalModification
|
disease |
BEFREE |
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
|
17890317 |
2007 |
|
Primary malignant neoplasm of lung
|
0.070 |
PosttranslationalModification
|
disease |
BEFREE |
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
|
17890317 |
2007 |
|
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The miR-29a/b-1 cluster was significantly (and AD-dementia-specific) decreased in AD patients displaying abnormally high BACE1 protein.
|
18434550 |
2008 |
|
Presenile dementia
|
0.010 |
Biomarker
|
disease |
BEFREE |
The miR-29a/b-1 cluster was significantly (and AD-dementia-specific) decreased in AD patients displaying abnormally high BACE1 protein.
|
18434550 |
2008 |
|
Fibrosis
|
0.010 |
Biomarker
|
phenotype |
LHGDN |
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis.
|
18723672 |
2008 |
|
Rhabdomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.
|
18977326 |
2008 |
|
Dementia
|
0.010 |
Biomarker
|
disease |
BEFREE |
The miR-29a/b-1 cluster was significantly (and AD-dementia-specific) decreased in AD patients displaying abnormally high BACE1 protein.
|
18434550 |
2008 |
|
Malignant neoplasm of breast
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
We also observed enhanced miR-29a and reduced TTP levels in breast cancer patient samples, indicating relevance for human disease.
|
19247375 |
2009 |
|
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
We also observed enhanced miR-29a and reduced TTP levels in breast cancer patient samples, indicating relevance for human disease.
|
19247375 |
2009 |
|
Non-Small Cell Lung Carcinoma
|
0.360 |
AlteredExpression
|
disease |
BEFREE |
MiRNA expression profiling of human NSCLC cell lines indicated that miR-29a levels were reduced in more invasive cell lines.
|
19818597 |
2009 |
|
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In this study we have identified a functional role for miR-29a in cancer cell invasion and proliferation.
|
19818597 |
2009 |
|
Neoplasm Metastasis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Overexpression of miR-29a suppressed the expression of tristetraprolin (TTP), a protein involved in the degradation of messenger RNAs with AU-rich 3'-untranslated regions, and led to EMT and metastasis in cooperation with oncogenic Ras signalling.
|
19247375 |
2009 |
|
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
In this study we have identified a functional role for miR-29a in cancer cell invasion and proliferation.
|
19818597 |
2009 |
|
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
In this study we have identified a functional role for miR-29a in cancer cell invasion and proliferation.
|
19818597 |
2009 |
|
Malignant neoplasm of lung
|
0.070 |
Biomarker
|
disease |
BEFREE |
We conclude that miR-29a has a significant anti-invasive and anti-proliferative effect on lung cancer cells in vitro and functions as an anti-oncomir.
|
19818597 |
2009 |
|
Carcinoma of lung
|
0.070 |
Biomarker
|
disease |
BEFREE |
We conclude that miR-29a has a significant anti-invasive and anti-proliferative effect on lung cancer cells in vitro and functions as an anti-oncomir.
|
19818597 |
2009 |
|
Primary malignant neoplasm of lung
|
0.070 |
Biomarker
|
disease |
BEFREE |
We conclude that miR-29a has a significant anti-invasive and anti-proliferative effect on lung cancer cells in vitro and functions as an anti-oncomir.
|
19818597 |
2009 |
|
Malignant neoplasm of breast
|
0.400 |
Biomarker
|
disease |
CTD_human |
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
|
20099276 |
2010 |
|
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
|
20099276 |
2010 |
|
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
|
20099276 |
2010 |
|
Mammary Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
|
20099276 |
2010 |
|
Mammary Carcinoma, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
|
20099276 |
2010 |
|
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The database search on TargetScan, PicTar and miRBase Target identified neurone navigator 3 (NAV3), a regulator of axon guidance, as a principal target of miR-29a, and actually NAV3 mRNA levels were elevated in AD brains.
|
20202123 |
2010 |
|
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
This study was designed to investigate the effect of members of the microRNA-29 family on the expression of cell division cycle 42 (Cdc42) and their roles on proliferation, migration, and invasion of gastric cancer cells.
|
20507733 |
2010 |